Doctor Ranks Every Popular Supplement (Do They Actually Work?)

Overview

The video evaluates popular supplements by comparing the specific health claim being made with the quality of evidence behind it. The presenter gives each claim a positive, negative, or cautious rating. A supplement may have evidence for one use or group of people but not for another.

The presenter emphasizes that:

• Interesting changes in biomarkers do not necessarily mean fewer heart attacks, fractures, or other meaningful health outcomes.
• Results depend on the person, dose, product, and health condition.
• “Not recommended” means evidence does not currently support the claim; it does not necessarily mean the supplement is harmful.
• Ratings may change as new research appears.

Main lessons about supplements

1. Bigger promises often have weaker evidence. Claims about slowing aging or preventing death require especially strong evidence.
2. The evidence should match the promise. A change in a lab measure or biological process does not by itself prove a health benefit.
3. Popularity is not proof. Marketing and online testimonials are not substitutes for controlled research.
4. Benefits can be population-specific. A supplement may help people with a deficiency or particular condition without benefiting everyone.
5. More is not necessarily better. Megadoses may offer no extra benefit and can cause harm.
6. Supplements cannot make up for a poor diet. They are intended to supplement, not replace, a sound dietary pattern.
7. Check the exact product and dose. Supplements may vary widely in their contents, and some can interact with medications. The presenter advises consulting a clinician, particularly during pregnancy or when managing a health condition.

Supplement assessments

Aging and skin

• Rapamycin — Not recommended for anti-aging. It affects the mTOR pathway and is used as a prescription drug to suppress immunity after organ transplants. Human findings on well-being, infections, and cholesterol are mixed, and there is no evidence that it slows aging or extends human lifespan.
• Metformin — Supported for diabetes, not as a general anti-aging supplement. Evidence supports improved blood-sugar control and reduced diabetes complications. Findings in people without diabetes or prediabetes are mixed; the presenter does not recommend it for healthy people seeking to slow aging.
• Resveratrol — Not recommended as a general anti-aging supplement. Some studies suggest possible metabolic, kidney, memory, or inflammation benefits, but results are inconsistent. A study in older adults found it blunted some exercise improvements, and Alzheimer’s trials reported faster brain-volume loss, though the clinical meaning is unclear.
• NAD precursors such as NR and NMN — Not recommended based on current evidence. They can raise NAD levels, but a systematic review found little clinical benefit in humans.
• Collagen for skin — Very weak, uncertain support. Some studies report better skin elasticity or moisture, and occasionally fewer wrinkles, but findings vary; wrinkle results appear particularly unconvincing.

Exercise, muscle, and protein

• Creatine monohydrate for strength and muscle — Strongly supported when combined with resistance exercise. Many randomized studies report gains in strength and muscle mass. A typical study dose is 3–5 g daily; a loading phase of about 20 g daily for a week is optional.
  • In people with healthy kidneys, studies described in the video did not find worsened kidney function. Creatine can raise creatinine, which may make kidney function appear worse on that measure alone. People with chronic kidney disease should consult their doctor because evidence in that group is limited.
  • The human evidence discussed did not raise a cancer concern, although decades-long data are limited.
  • The evidence does not support the claim that creatine causes hair loss.
• Protein powder — Supported as a convenient way to increase protein intake. With training, it can help strength, muscle, and body composition; evidence for a small reduction in body fat is less conclusive. The presenter says benefits level off at about 1.6 g of total protein per kg of body weight per day. Whey is well studied, but plant-based options such as soy can also contribute. The video says concerns about heavy metals are often exaggerated, though product quality can vary.

Heart health and blood sugar

• Vitamin K2 for heart health — Not supported at present. Some recent studies suggest it may slow arterial calcium accumulation, but that does not prove fewer heart attacks or strokes. The presenter says suitable trials measuring those outcomes are lacking. He says he does not take it for heart health or give it to his family for that purpose.
• Fermented red yeast rice — Cautious, product- and population-specific support. A large study of people who had already had heart attacks found fewer cardiac complications and lower overall mortality with a particular Chinese extract, Xuezhikang, over more than four years. The study has not been replicated and does not establish benefit for healthy people or all products.
  • Its active compound, monacolin K, is chemically identical to lovastatin. Monacolin K content varies greatly among retail brands, so the label may not reliably indicate the dose. The video suggests third-party certification as one way to check product contents.
• Fish oil / omega-3 for heart health — Uncertain and dependent partly on diet. A large trial found no overall reduction in cardiovascular outcomes, but a secondary analysis found fewer heart attacks among people who ate little fish. The presenter considers benefit unlikely for people who regularly eat omega-3-rich fish, while acknowledging uncertainty for those who do not.
  • Very high doses may increase atrial-fibrillation risk. The presenter generally tries to stay below 1–1.5 g daily. Prescription-strength omega-3 for very high triglycerides is a different use and should be managed by a clinician.
• Nattokinase — Not recommended for heart health. Preliminary claims are not backed by adequately designed trials of important outcomes such as heart attack or stroke. The longest randomized trial discussed found no improvement in artery-wall measures or blood tests at its lower dose.
• Coenzyme Q10 — Generally not recommended, with a cautious possible exception for heart failure. Trials have not shown consistent benefit for people taking statins. One randomized trial suggests possible benefit in heart failure, but the presenter notes that the evidence is limited.
• Serrapeptase — Not recommended for preventing heart attacks or clearing arteries. Some postsurgical research suggests possible effects on swelling and pain, but it has not been tested in humans for the proposed heart-health uses.
• Special salts such as Himalayan pink or Celtic sea salt — No established health advantage. They contain trace minerals, but in negligible amounts, and are still mostly sodium chloride. Many are not iodized, so people replacing iodized table salt should ensure they get iodine elsewhere.
• Berberine — Supported for blood-sugar control in people with diabetes or abnormal glucose, but not as a general supplement for healthy people. Randomized studies report lower blood sugar and some evidence of improvements in cholesterol, triglycerides, and blood pressure. Calling it “natural metformin” overstates the evidence: it has not been shown to reduce diabetes complications or mortality in the way metformin has in the evidence described. Possible issues include gastrointestinal symptoms and medication interactions.
• “Anti-Spike” — Not recommended for blood-sugar control. The presenter says the combined product has not been tested scientifically in humans and that ingredients cannot be assumed to retain their individual effects when mixed.
• AG1 / Athletic Greens — The presenter rejects its broad claims. The largest study discussed found no improvement in several measured blood tests, and reported digestion changes were not significant. The presenter argues that people with a poor diet may simply need more nutrients, which can be obtained more cheaply, and that vague marketing and testimonials are not reliable evidence.

Bone health and osteoarthritis

• Vitamin D and calcium — Not routinely beneficial for everyone in preventing fractures. Large studies in the general population have often found no reduction in fractures or falls. A study in very elderly nursing-home women with relatively low calcium intake did find fewer fractures with both supplements.
  • The presenter favors getting these nutrients from food where possible and considering supplements when intake is inadequate or needs are higher. He identifies people with limited sun exposure, dietary restrictions, absorption problems, osteoporosis, and children or pregnant people as groups for whom vitamin D may require special attention.
  • He suggests 1,000–2,000 IU of vitamin D daily as a maintenance amount for people unsure whether they get enough, absent special conditions or a clear deficiency. Calcium is preferably obtained from food; supplements may increase kidney-stone risk in some people.
• Vitamin K2 for bone health — Mixed, population- and form-specific evidence. Some Japanese studies in postmenopausal women with osteoporosis reported fewer fractures with high-dose MK-4 (about 45 mg daily), but a larger trial and later reviews did not show a clear fracture-prevention benefit. The presenter gives a weak, cautious endorsement only for that specific form, dose, and population—not for general use or low-dose MK-7. K2 may interact with anticoagulants.
• Osteoarthritis symptoms — Some trial evidence for symptom relief. The presenter cites collagen, glucosamine, chondroitin, and turmeric extracts as having research suggesting possible reductions in pain or swelling for people with osteoarthritis.

Brain health

• Omega-3 — Possible modest benefit mainly when baseline intake or levels are low. Some studies report improvements in memory or other cognitive measures, while many find no benefit. The presenter says extra supplements are unlikely to help people who already eat fish and seafood regularly; people with low omega-3 intake may benefit, though this is not certain. Evidence is less encouraging in people who already have Alzheimer’s disease.
  • Fish oil and algal oil can both raise omega-3 levels. Some algal products contain mostly DHA and little EPA, so the presenter advises checking the label.
• Creatine — Cautiously supported for cognition, especially for some groups. Possible benefits for memory and attention appear more relevant to older adults, people under stress or short on sleep, and people who consume little creatine in their diets, such as vegetarians and vegans. This evidence is less established than the evidence for muscle and strength. A loading phase is not required for the brain.
• Multivitamins — Cautiously supported for some older adults. The presenter cites a trial reporting improved general cognitive abilities and some memory measures, as well as a review showing improvement on one particular memory test. Benefits may be more likely among people with poor diets, low appetites, or digestive problems. He cautions against megadoses.
• Essential nutrients such as B12 and folate — Obtain through food where possible; supplement when intake is insufficient.

Sleep, stress, and digestion

• Melatonin — Modest help for insomnia; more useful for jet lag or shifting circadian timing. On average, it helped people fall asleep about 7 minutes faster and stay asleep about 8 minutes longer, with possible small improvements in sleep quality. Individual results vary.
• Ashwagandha — Cautious short-term support for stress and anxiety; possible modest sleep benefit. Studies commonly used hundreds of milligrams per day, often 200–600 mg, though products and doses differ. Long-term safety evidence is limited. The presenter flags pregnancy, liver disease, possible liver injury, thyroid effects, and medication interactions as reasons for caution.
• Magnesium — Not well supported for sleep or muscle spasms; better evidence for other uses. The presenter cites modest blood-pressure reduction, help with migraines, and use as a laxative for constipation. It is an essential nutrient, so supplementation may be appropriate when dietary intake is inadequate.
• L-theanine — Cautiously supported for sleep. The presenter says growing evidence and some meta-analyses suggest a benefit.
• Psyllium husk — Supported for constipation and loose stools. It can help normalize stool consistency in either direction. Because it is fiber, the presenter advises starting with a small amount and increasing gradually to reduce bloating and gas.
• Probiotics — Use only for specific strains and situations, not as a generic “gut health” product. Effects vary by strain, dose, and product; some probiotic combinations may interfere with microbiome recovery after antibiotics. Lactobacillus rhamnosus GG and Saccharomyces boulardii are cited as having evidence for preventing antibiotic-associated diarrhea. Evidence for other uses, such as IBS, is less clear. People with weakened immune systems should be especially cautious because infections can occur.

Supplements the presenter says he takes

The presenter says he takes an algae-based omega-3 because he eats little fish and seafood, and vitamin D because he does not get enough from food. He says he does not take K2 for heart health or use it for his family.

Speakers and sources featured

• Speaker: The video’s narrator/presenter, a physician discussing his interpretation of research and his personal supplement choices. No other speaking interviewees are identified in the subtitles.
• Research sources discussed: Randomized controlled trials, long-term trials, systematic reviews, meta-analyses, and individual observational or preliminary studies. The presenter also refers to animal research, though he distinguishes it from evidence in humans.
• Other sources mentioned: An article on the Harvard website and recommendations or views from professional health organizations regarding omega-3 supplements and brain function.
• Testimonials: Online customer stories and product reviews are discussed as marketing material, not as reliable scientific sources.